Woodline Partners
38 portfolio companies · 9 on the map · $2.4B raised · 8 cities
Portfolio map
9 Woodline Partners portfolio companies on the map.
Portfolio companies

Immunome
Bothell
Immunome is a biotechnology company that specializes in immunotherapy, biotechnology, and antigen discovery.
Biotechnology Research$998.9M
Amylyx Pharmaceuticals
Cambridge
Amylyx Pharmaceuticals specializes in providing solutions for Alzheimer’s and other diseases of the brain.
Pharmaceutical Manufacturing$623.5M
Skyryse
Los Angeles
Skyryse is an aviation hardware and software company dedicated to improving flight safety.
Aerospace and Defense$300MEst. 2016
Mirador Therapeutics
San Diego
Mirador Therapeutics develops precision medicines for immune-mediated diseases.
Biotechnology Research$250MEst. 2024
Hansa Biopharma
Lund
Hansa Biopharma is a biopharmaceutical company that develops immunomodulatory treatments for people living with rare immunological diseases.
Biotechnology Research$205.2MEst. 2007
Archive
San Francisco
Archive.com operates the leading AI-powered social commerce platform.
SaaS$8.1MEst. 2021AnaptysBio
San Diego
AnaptysBio is a biotechnology company that develops antibody therapeutics based on somatic hypermutation.
Biotechnology ResearchPublicEst. 2005Tectonic Therapeutic
Watertown
Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.
BiotechnologyPublicEst. 2019
ElevateBio
Waltham
ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.
Pharmaceutical ManufacturingSeries DEst. 2017Hiring fast
More portfolio companies
26 more Woodline Partners investments we track beyond the map — 38 tracked in total.
TalkspaceNew York · Post-IPO Equity
Caris Life SciencesIrving · Private Equity
Ursa MajorBerthoud · Series E
Build A Rocket BoyEdinburgh · Series D
Beauty Health CompanyLong Beach · Post-IPO Equity
CARGO TherapeuticsSan Mateo · Post-IPO Equity
PatreonSan Francisco · Series F
SmartNewsTokyo · Series F
ElektrofiBoston · Series C
Affinia TherapeuticsWaltham · Series B
Protara TherapeuticsNew York · Post-IPO Equity
FormoBerlin · Series B
Enliven TherapeuticsBoulder · Post-IPO Equity
Soleno TherapeuticsRedwood City · Post-IPO Equity
NeoGenomicsFort Myers · Post-IPO Equity
KALA BIOWaltham · Post-IPO Equity
Lyra TherapeuticsWatertown · Post-IPO Equity
SharecareAtlanta · Post-IPO Equity
EquilliumLa Jolla · Post-IPO Equity
Fusion PharmaceuticalsHamilton · Post-IPO Equity
Eledon PharmaceuticalsIrvine · Post-IPO Equity
ProMIS NeurosciencesToronto · Post-IPO Equity
Kalaris Therapeutics (formerly AlloVir)Houston · Post-IPO Equity
Point BiopharmaIndianapolis · Post-IPO Equity
RezoluteLouisville · Post-IPO Equity
MindMedNew York · Post-IPO Equity
Portfolio map
9 Woodline Partners portfolio companies on the map.